| Timo J Hoggard, MD OB | |
|
226 N 1100 E, Suite A, American Fork, UT 84003-2054 | |
| (801) 855-3850 | |
| (801) 855-3854 |
| Full Name | Timo J Hoggard |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 226 N 1100 E, American Fork, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639288798 | NPI | - | NPPES |
| D1417 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2719251205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| American Fork Hospital | American fork, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Family Medical | 7416197785 | 71 |
News Archive
Spina bifda (SB) is a complex congenital central nervous system disease that is caused by the incomplete closing of the neural tubes during the embryonic phase.
As many Americans resolve to lose weight and lead healthier lifestyles in the new year, U.S. News & World Report today released its Best Diets 2014, featuring rankings and information on 32 diet plans.
Researchers are developing low-cost technologies to tackle indoor air pollution that is a growing menace. A new generation of electrostatic filters can capture even the smallest particles of household pollutants, using a little amount of energy.
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule 5550(a)(2) because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share.
› Verified 3 days ago
| Entity Name | Premier Family Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750725735 PECOS PAC ID: 7416197785 Enrollment ID: O20130710000079 |
News Archive
Spina bifda (SB) is a complex congenital central nervous system disease that is caused by the incomplete closing of the neural tubes during the embryonic phase.
As many Americans resolve to lose weight and lead healthier lifestyles in the new year, U.S. News & World Report today released its Best Diets 2014, featuring rankings and information on 32 diet plans.
Researchers are developing low-cost technologies to tackle indoor air pollution that is a growing menace. A new generation of electrostatic filters can capture even the smallest particles of household pollutants, using a little amount of energy.
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule 5550(a)(2) because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timo J Hoggard, MD OB 226 N 1100 E, Suite A, American Fork, UT 84003-2054 Ph: (801) 855-3850 | Timo J Hoggard, MD OB 226 N 1100 E, Suite A, American Fork, UT 84003-2054 Ph: (801) 855-3850 |
News Archive
Spina bifda (SB) is a complex congenital central nervous system disease that is caused by the incomplete closing of the neural tubes during the embryonic phase.
As many Americans resolve to lose weight and lead healthier lifestyles in the new year, U.S. News & World Report today released its Best Diets 2014, featuring rankings and information on 32 diet plans.
Researchers are developing low-cost technologies to tackle indoor air pollution that is a growing menace. A new generation of electrostatic filters can capture even the smallest particles of household pollutants, using a little amount of energy.
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule 5550(a)(2) because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share.
› Verified 3 days ago
Michael L Cosgrave, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 N 1100 E, Suite A, American Fork, UT 84003 Phone: 801-855-3844 Fax: 801-855-3854 | |
Douglas R Mower, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 N 1100 E, Suite A, American Fork, UT 84003 Phone: 801-855-3841 Fax: 801-855-3847 | |
Kenneth Joe Murdock, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 226 N 1100 E, Suite A, American Fork, UT 84003 Phone: 801-855-3841 Fax: 801-855-3854 | |
David K Hafen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 N 1100 E, Suite A, American Fork, UT 84003 Phone: 801-855-3850 Fax: 801-855-3854 | |
Andrew Reid Smith, Family Medicine Medicare: Medicare Enrolled Practice Location: 98 N 1100 E Ste 101, American Fork, UT 84003 Phone: 801-492-2550 | |
James L Clark, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 383 E 60 S, American Fork, UT 84003 Phone: 801-576-6417 | |
Dr. Mark K Hafen, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 226 N 1100 E Ste A, American Fork, UT 84003 Phone: 801-855-3848 Fax: 801-855-3854 |